GTC
KYNB

Ghost Tree Capital’s Kyntra Bio KYNB Stock Holding History

Ghost Tree Capital’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,460
Closed -$98.5K – 73
2023
Q2 		$98.5K Buy
1,460
+400
+38% +$165K 0.03% 57
2023
Q1 		$494K Buy
+1,060
New +$561K 0.15% 55
2021
Q2 		– Sell
-5,000
Closed -$4.34M – 59
2021
Q1 		$4.34M Buy
+5,000
New +$5.32M 1.02% 35
2019
Q2 		– Sell
-460
Closed -$625K – 47
2019
Q1 		$625K Buy
+460
New +$624K 0.16% 39

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ghost Tree Capital's KYNB Position: Q3 2023 in Review

Ghost Tree Capital sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 1,460 shares — an estimated $98.5K sold.

Ghost Tree Capital first reported a position in KYNB in Q1 2019 and held it in 4 quarters. The position peaked at $4.34M in Q1 2021. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Ghost Tree Capital reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Ghost Tree Capital sold 1,460 Kyntra Bio shares in Q3 2023, an estimated $98.5K.
  • Ghost Tree Capital first reported a position in Kyntra Bio in Q1 2019 and held it in 4 quarters.
  • Ghost Tree Capital's Kyntra Bio position peaked at $4.34M in Q1 2021.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Ghost Tree Capital's 13F filing for Q3 2023, filed 14 Nov 2023.